WO2015196752A1 - Procédé et nécessaire de construction rapide d'une banque de séquençage d'adn plasmatique - Google Patents

Procédé et nécessaire de construction rapide d'une banque de séquençage d'adn plasmatique Download PDF

Info

Publication number
WO2015196752A1
WO2015196752A1 PCT/CN2014/093698 CN2014093698W WO2015196752A1 WO 2015196752 A1 WO2015196752 A1 WO 2015196752A1 CN 2014093698 W CN2014093698 W CN 2014093698W WO 2015196752 A1 WO2015196752 A1 WO 2015196752A1
Authority
WO
WIPO (PCT)
Prior art keywords
sequencing
dna
plasma dna
filling
enzyme
Prior art date
Application number
PCT/CN2014/093698
Other languages
English (en)
Inventor
Di Chen
Yali Li
Tiancheng Li
Yanbin SHI
Jianghua ZHANG
Kai Wu
Original Assignee
Berry Genomics Co., Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berry Genomics Co., Ltd filed Critical Berry Genomics Co., Ltd
Publication of WO2015196752A1 publication Critical patent/WO2015196752A1/fr

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Definitions

  • the present invention is directed to a method and a kit for quickly constructing a plasma DNA sequencing library. More specifically, the present invention is directed to a method and a kit for quickly constructing a plasma DNA library for high throughput sequencing.
  • the main principle of the high throughput sequencing technology is sequencing by synthesis, namely, determining DNA sequences by capturing newly synthesized end labelling.
  • the available technologic platform mainly includes Roche/454 FLX, Illumina/Hiseq, Miseq, NextSeq and Life Technologies/SOLID system, PGM, Proton, and the like.
  • HiSeq 2000 can reach a sequencing throughput of 30X coverage in 6 human genomes per run, i.e., about 600 G/run. With respect to sequencing time, Hiseq 2500 can reach a speed of reading a base per 8 minutes on average. Furthermore, with the maturity of the second generation sequencing technology, the investigation on its clinical application has developed quickly.
  • Plasma DNA also known as circulating DNA
  • Plasma DNA is an extracellular DNA in the blood and is tens to hundreds of nucleotides in length. It presents in the form of DNA-protein complex, or as free DNA fragment.
  • plasma DNA is derived from DNA release of a small amount of senescent and dead cells. Under healthy condition, the generation and removal of the circulating DNA are in dynamic equilibrium and are maintained at a relatively steady low level.
  • the circulating DNA can reflect the metabolic condition of cells in human body, thus is an important index for judging health.
  • the change of quantity and quality of circulating DNA in peripheral blood is closely related to several diseases (including tumour, complex severe traumata, organ transplantation, pregnancy-related diseases, infectious diseases, organ failure, and the like) .
  • As a non-invasive detection index it is expected to be an important molecular marker for early diagnosing some diseases, monitoring the diseases and evaluating the therapeutic effects and prognosis of the diseases.
  • Plasma DNA carries all the genetic information of the cancer cell genomes (Schwarzenbach, Hoon et al. 2011) . Recently, Professor Yuming LU distinguished cancer patients and healthy individuals by carrying out high throughput sequencing on the plasma DNA of cancer patients to calculate the methylation condition of the repeats (Chan, Jiang et al. 2013) .
  • the preparation process of plasma DNA sample for the second generation high throughput sequencing substantively lies in inserting a DNA with a suitable sequencing length into a known sequencing vehicle, namely, adding linkers with known sequence to both ends of a DNA to be sequenced.
  • a plasma DNA library mainly includes key steps such as extraction of a plasma DNA, terminal repair and 5’ terminal phosphorylation, then the addition of A on the end, connection of the linkers, PCR and the like (Fig. 1 ) , in which a purification step is needed almost between every two steps.
  • Such a method for constructing a plasma DNA sequencing library totally needs 6 main enzymes, 4 enzyme reaction systems, and 4 purification processes, thus result in higher cost and complex operation.
  • the inventor found a new simpler, quicker, and evener method for constructing a plasma DNA sequencing library, which is applicable to multiple second generation sequencing platforms, including, but not limited to, Roche/454 FLX, Illumina/Hiseq, Miseq and Life Technologies/SOLID system, PGM, Proton and the like.
  • the invention is based on the following facts: the inventor has found that the plasma DNA can be sequenced after connected to a sequencing linker without PCR amplification; the amplification step in the current experimental process is not necessary; and the use of PCR polymerase is not necessary either. The inventor has also found that the three steps of end-filling, addition of A on the end and the connection of sequencing linkers in the current experimental process can be completed in one reaction system without purification step therebetween. Additionally, the end-filling process of the plasma DNA can be carried out without 5′end phosphorylation. The library to be sequenced can be obtained after the final purification.
  • a plasma DNA library can be well constructed and effective sequencing results can be obtained even when the amount of fractured plasma DNA within an organism is as low as 2 ng. Moreover, the present invention firstly applies PCR free technology to extremely low amount (less than 10 ng) of plasma DNA.
  • the present invention provides a method for constructing a plasma DNA sequencing library, comprising the following steps:
  • the plasma DNA sequencing library can be obtained without the reaction step of PCR amplification of the purified product.
  • step 4) of connecting the 3′end-added A plasma DNA with a sequencing linker to obtain a connected product is carried out by one or two enzymes selected from the group consisting of T4 DNA ligase and T7 DNA ligase.
  • the sequencing linker is a double-stranded sequencing linker.
  • the double-stranded linker according to the present invention is obtained by annealing two single-stranded DNAs: one is a universal sequence, namely, this DNA has fixed sequences and has an identical application in different libraries, such as the universal adaptor shown hereinafter; the other one is a sequence with an index, namely, the sequence of this DNA has its specific bases (generally 3-8 specific bases) to distinguish between different linker sequences, wherein the sequences other than the specific bases are fixed, such as the index adaptor shown hereinafter.
  • linker sequences used in the present invention are as follows.
  • linker sequences are merely examples of linker sequences of the present invention. According to the different sequencing platforms, such as Illumina, Ion Torrent, and Roche 454, those skilled in the art can connect different and suitable linker sequences to the plasma DNA library of the invention.
  • A is added on the end of the extracted plasma DNA, and the end-added A plasma DNA is purified.
  • a klenow ex-enzyme, a Taq enzyme, or a combination thereof is used during the addition of A on the end.
  • the addition of A on the end and the connection with sequencing linkers can be carried out in one reaction system, namely, the connection of sequencing linkers can be directly carried out after the addition of A on the end without purification.
  • the plasma DNA is purified to obtain the plasma DNA library to be sequenced.
  • Taq enzyme is used during the addition of A on the end.
  • the extracted plasma DNA is end-filled and A is added on the end.
  • the end-filling and the addition of A on the end can be carried out in two reaction systems, namely, the end-filled plasma DNA is purified before the addition of A on the end. Alternatively and preferably, the end-filling and the addition of A on the end are carried out in one reaction system. After the end-filling and the addition of A on the end, the plasma DNA is purified. T4 DNA polymerase is used during the end-filling, and Taq enzyme is used during the addition of A on the end.
  • the end-filling and the addition of A on the end as well as connecting the plasma DNA with the sequencing linker are carried out in one reaction system.
  • the plasma DNA is purified to obtain the plasma DNA library to be sequenced.
  • the plasma DNA merely needs one reaction system, and the final sequencing library can be obtained after once purification.
  • T4 DNA polymerase is used during the end-filling, and Taq enzyme is used during the addition of A on the end.
  • the present invention provides a kit for constructing a plasma DNA sequencing library, comprising:
  • -Reagents for optionally end-filling the plasma DNA including dNTP, enzymes for the end-filling, and buffers for the end-filling;
  • -Reagents for adding A on the 3′end including dATP, enzymes for adding A on the end, and buffers for adding A on the end;
  • -Reagents for connecting a sequencing linker including sequencing linkers, ligases, and connecting buffer;
  • the kit does not comprise polymerase for PCR amplification.
  • the present invention provides a kit for constructing a plasma DNA sequencing library, an important feature of the kit is that the plasma DNA connected with the linker becomes a library to be sequenced after purification without the step of PCR amplification.
  • the ligase is one or two enzymes selected from the group consisting of T4 DNA ligase and T7 DNA ligase.
  • the sequencing linker is a double-stranded sequencing linker.
  • a klenow ex-enzyme, a Taq enzyme, or a combination thereof is used during the addition of A on the end.
  • the kit of the present invention comprises: reagents for end-filling and adding A on the end of the extracted plasma DNA, including enzymes for the end-filling, dNTP, buffers for the end-filling, dATP, enzymes for adding A on the end, and buffers for adding A on the end; and reagents and devices for purifying the plasma DNA after the end-filling and the addition of A on the end.
  • the end-filling and the addition of A on the end are carried out in one reaction system, whereinT4 DNA polymerase is used during the end-filling, and Taq enzyme is used during the addition A on the end.
  • the kit of the present invention comprises: reagents for end-filling and adding A on the end of the extracted plasma DNA, including enzymes for the end-filling, dNTP, buffers for the end-filling, dATP, enzymes for adding A on the end, and buffers for adding A on the end; and reagents for connecting the plasma DNA with a sequencing linker, including sequencing linkers, ligases, and connecting buffers.
  • reagents for end-filling and adding A on the end as well as connecting the plasma DNA with the sequencing linker are carried out in one reaction system, wherein T4 DNA polymerase is used during the end-filling, and Taq enzyme is used during the addition A on the end.
  • the kit does not comprise a polymerase for PCR amplification, and does not comprise purification reagents and devices after the end repair and the addition of A on the 3′end.
  • reagents for purifying the connected product is sterile dH 2 O or an elution buffer
  • devices for purifying the connected product is a purification column, a Qiagen column, purification magnetic beads or Beckman Ampure XP beads.
  • the present invention omits PCR reaction step from the existing method for constructing a plasma DNA sequencing library and no longer uses PCR polymerase. Additionally, based on this, the present invention replaces the klenow ex-enzyme by a conventional Taq enzyme for the addition of A on the end, so that various reaction systems become compatible: the end-filling, the addition of A on the end and the connection of sequencing linkers can be completed in one reaction system without purification step therebetween. Therefore the present invention greatly simplifies the process for constructing a plasma DNA sequencing library, reduces sample confusion and contamination caused by manual operation, and thus is more suitable for large-scale operation of plasma DNA library construction.
  • the present invention removes the contamination of environment as well as among samples due to PCR amplification, reduces the requirement for environment during the plasma DNA library construction, and removes the base preference, asymmetry coverage on the genome and the inaccuracy of the sequencing results due to PCR amplification.
  • the present invention enables plasma sample library construction to be cheaper, more efficient and quicker, and also enables plasma DNA sequencing results to be more authentic and effective. Therefore, the present invention is more suitable for large-scale experimental operation and sequential analysis of the plasma DNA.
  • Fig. 1 shows the method for constructing the second generation high throughput plasma DNA sequencing library commonly used in the prior art.
  • Fig. 2 shows the method for constructing the second generation high throughput plasma DNA sequencing library according to one embodiment of the invention.
  • Fig. 3 shows the comparison of two different methods for constructing a library according to the prior art and one embodiment of the invention.
  • Fig. 4 shows the comparison of four different methods for constructing a library according to Examples 1-4 of the invention.
  • the method for constructing a plasma DNA library applicable to the second generation high throughput sequencing platform used in the prior art mainly includes the following steps (Fig. 1) : extracting a plasma DNA (step 101) ⁇ end-repairing (filling) the extracted plasma DNA, phosphorylating 5’ end, and purifying (step 102) ⁇ Adding A on the 3′end of the 5’ end-phosphorylated DNA fragment, and purifying (step 103) ⁇ connecting the 3′end-added A DNA with a sequencing linker (step 104) ⁇ purifying the connected product to remove the un-connected linkers (step 105) ⁇ carrying out PCR reaction with the purified product (step 106) ⁇ purifying the PCR product to obtain a plasma DNA sequencing library (step 107) .
  • the method for constructing the second generation plasma DNA sequencing library totally needs 6 main enzymes, 4 enzyme reaction systems, 4 purification processes and 1PCR amplification, thus has a higher cost and complex operation. Additionally, it requests for more strict condition, is easier to form aerosol pollution, and meantime requires higher operational capacity in molecular biology for the experimenter. Moreover, it is more difficult to achieve simultaneous processing of multiple samples. Furthermore, aerosol pollution caused during the PCR process is extremely easily to contaminate the sequencing sample, and the PCR process may also introduce a certain base preference, thereby causing asymmetry of sequencing results in coverage on the genome and finally resulting in inaccuracy in the results.
  • the inventor has found that the plasma DNA can be sequenced after attached to a sequencing linker without PCR amplification.
  • the amplification step in the current experimental process is not necessary.
  • an important feature of the present invention for constructing a plasma DNA sequencing library is that the present invention does not comprise the step of PCR amplification.
  • the inventor has also found that, according to the selection of the enzyme used in the addition of A on the end, the three steps of end-filling, addition of A on the end and the connection of sequencing linkers in the current experimental process do not need to be carried out in three reaction systems, but can be completed in one reaction system without purification step therebetween.
  • Fig. 2 shows the method for constructing the second generation high throughput plasma DNA sequencing library according to one embodiment of the invention, mainly includes the following steps (Fig. 2) : extracting a plasma DNA (step 201) ⁇ end-filling and adding A on the end of the extracted plasma DNA (step 203) ⁇ connecting the 3′end-added A plasma DNA with a sequencing linker (step 204) ⁇ purifying the plasma DNA connected with a linker to obtain a plasma DNA sequencing library (step 207) .
  • step 203 can be carried out in two reaction systems, namely, step 202 (end-repairing the extracted plasma DNA, and phosphorylating 5’ end) is carried out before step 203 (adding A on the 3′end of the 5’ end-phosphorylated DNA fragment) ; or a purification step is carried out between steps 203 and 204.
  • the method of the present invention merely needs one reaction system and one step of purification without PCR process to obtain the final library to be sequenced. Therefore the present invention greatly simplifies the process for constructing a plasma DNA sequencing library, removes the base preference and asymmetry coverage on the genome due to the introduction of PCR steps.
  • the present invention enables the plasma sample library construction to be cheaper, more efficient and quicker, and also enables the plasma DNA sequencing results to be more authentic and effective, thus is more suitable for large-scale use.
  • the method for constructing a plasma DNA sequencing library of example 1 mainly includes the following steps (Fig. 4) :
  • Extracting a plasma DNA this step can be carried out using any methods and reagents well known to one skilled in the art and suitable for extracting a plasma DNA.
  • this step can be carried out using any methods and reagents well known to one skilled in the art and suitable for end-filling, cleaning and purifying.
  • T4 DNA polymerase and Klenow enzyme can be used as the enzyme for end-filling.
  • this step can be carried out using any methods and reagents well known to one skilled in the art and suitable for adding A on the end, cleaning and purifying.
  • a base can be added on the double-stranded end of the product obtained from step (2) in the presence of klenow ex-enzyme (New England Biolabs) (it is an improved enzyme lacking 3’ -5’ exonuclease activity) .
  • this step can be carried out using any methods and reagents well known to one skilled in the art and suitable for connecting a linker, cleaning and purifying.
  • the end-added A product can be connected with a double-stranded sequencing linker in the presence of T4 DNA ligase, T7 DNA ligase or both.
  • the sequencing linker is commercially available or can be obtained by synthesis.
  • linker sequences used in the present invention are as follows.
  • Step 1 about 5 ng plasma DNA was extracted.
  • Step 2 a mixture for end-filling reaction as shown in Table 1 was prepared and placed in a 20°C warm bath for 30min.
  • the DNA sample was purified on a purification column and eluted by 32 ⁇ l sterile dH 2 O or elution buffer.
  • the elution buffer used here was 10mM Tris-Cl, pH 8.0.
  • the elution buffers suitable for the invention are not limited to this.
  • Step 3 a reaction mixture for adding a poly-adenine tail on the 3’a s shown in Table 2 was prepared and placed in a 37°C warm bath for 30min.
  • the DNA sample was purified on a purification column and eluted by 37 ⁇ l sterile dH 2 O or elution buffer.
  • Step 4 a reaction mixture for connecting the DNA fragment with a sequencing linker as shown in Table 3 was prepared and placed in a 20°C warm bath for 15min, followed by a 65°C warm bath for 10min, and was then maintained at 4°C.
  • the connected plasma DNA sample was recovered by Beckman Ampure XP beads and eluted by 22 ⁇ l sterile dH 2 O or elution buffer.
  • Step 5 Quantification and mix of the library: 1 ⁇ L library was sampled and quantified by qPCR, and it was qualified if the concentration of the library was greater than or equal to 20pM. The samples with different linkers in one channel were mixed equally according to the arrangement of the channels. 1 ⁇ L mixture was sampled and quantified again by qPCR.
  • Step 6 Sequencing: the first end sequencing primer, tag primer and the second end sequencing primer were diluted into 100 ⁇ M and sequenced according to the operation instruction of Illmina Hiseq2000. Alternatively, double-ended sequencing or single-ended sequencing can be carried out. The second end sequencing primer is not required when the single-ended sequencing is carried out.
  • Example 2 The method for constructing a plasma DNA sequencing library according to Example 2 is substantively similar to that of Example 1, except that Example 2 omitted the step of end-filling.
  • the extracted plasma DNA was directly added A and purified (see Fig. 4) .
  • Step 1 about 5 ng plasma DNA was extracted.
  • Step 2 a reaction mixture as shown in Table 4 was prepared and placed in a 37°C warm bath for 30min for adding a poly-adenine tail on the 3’ end of the DNA fragment.
  • the DNA sample was purified on a purification column and eluted by 37 ⁇ l sterile dH 2 O or elution buffer.
  • Step 3 a reaction mixture for connecting the DNA fragment with a sequencing linker as shown in Table 5 was prepared and placed in a 20°C warm bath for 15rmin, followed by a 65°C warm bath for 10min, and was then maintained at 4°C.
  • the connected plasma DNA sample was recovered by Beckman Ampure XP beads and eluted by 22 ⁇ l sterile dH 2 O or elution buffer.
  • Step 4 Quantification and mix of the library: 1 ⁇ L library was sampled and quantified by qPCR, and it was qualified if the concentration of the library was greater than or equal to 20pM. The samples with different linkers in one channel were mixed equally according to the arrangement of the channels. 1 ⁇ L mixture was sampled and quantified again by qPCR.
  • Step 5 Sequencing: the first end sequencing primer, tag primer and the second end sequencing primer were diluted into 100 ⁇ M and sequenced according to the operation instruction of Illmina Hiseq2000. Alternatively, double-ended sequencing or single-ended sequencing can be carried out. The second end sequencing primer is not required when the single-ended sequencing is carried out.
  • Example 3 The method for constructing a plasma DNA sequencing library according to Example 3 is substantively similar to that of Example 1, except that in Example 3, the end-filling and the addition A on the end were carried out in one reaction system without cleaning and purification steps therebetween.
  • the commonly used klenow ex-enzyme was replaced by a conventional Taq enzyme for the addition of A on the end, so that the two reaction systems became compatible (Fig. 4) .
  • Step 1 about 5 ng plasma DNA was extracted.
  • Step 2 a reaction mixture as shown in Table 6 was prepared and placed in a 37°C warm bath for 30min (for end-filling) and in a 72°C warm bath for 20min (for adding A on the end) , so that the end-filling and the addition of A on the end were carried out in one reaction system.
  • the DNA sample was purified on a purification column and eluted by 37 ⁇ l sterile dH 2 O or elution buffer.
  • the temperature and time for the end-filling and the addition of A on the end can vary according to the compositions of different reaction mixtures suitable for different design requirements.
  • Step 3 a reaction mixture for connecting the DNA fragment with a sequencing linker as shown in Table 7 was prepared and placed in a 20°C warm bath for 15min, followed by a 65°C warm bath for 10min, and was then maintained at 4°C.
  • the connected plasma DNA sample was recoverd by Beckman Ampure XP beads and eluted by 22 ⁇ l sterile dH2O or elution buffer.
  • Step 4 Quantification and mix of the library: 1 ⁇ L library was sampled and quantified by qPCR, and it was qualified if the concentration of the library was greater than or equal to 20pM. The samples with different linkers in one channel were mixed equally according to the arrangement of the channels. 1 ⁇ L mixture was sampled and quantified again by qPCR.
  • Step 5 Sequencing: the first end sequencing primer, tag primer and the second end sequencing primer were diluted into 100 ⁇ M and sequenced according to the operation instruction of Illmina Hiseq2000. Alternatively, double-ended sequencing or single-ended sequencing can be carried out. The second end sequencing primer is not required when the single-ended sequencing is carried out.
  • Example 1 The method for constructing a plasma DNA sequencing library according to Example 1 was substantively similar to that of Example 1, except that in Example 4, the end-filling, the addition of A on the end and the connection with a sequencing linker were carried out in one reaction system without cleaning and purification steps between the end-filling and the addition A on the end, or between the addition of A on the end and the connection with a sequencing linker.
  • the commonly used klenow ex-enzyme was replaced by a conventional Taq enzyme for the addition of A on the end, so that the three reaction systems became compatible (see Fig. 4) .
  • Step 1 about 5 ng plasma DNA was extracted.
  • Step 2 a reaction mixture as shown in Table 8 was prepared and placed in a 37°C warm bath for 30min (for end-filling) and in a 72°C warm bath for 20min (for adding A on the end) , so that the end-filling and the addition of A on the end were completed without a purification step.
  • Step 3 an additional reaction reagent was added into the above reaction solution.
  • a reaction mixture for connecting the DNA fragment with a sequencing linker as shown in Table 9 was prepared and placed in a 20°C warm bath for 15min, followed by a 65°Cwarm bath for 10min, and was then maintained at 4°C.
  • the connected plasma DNA sample was recovered by Beckman Ampure XP beads and eluted by 22 ⁇ l sterile dH 2 O or elution buffer.
  • Step 4 Quantification and mix of the library: 1 ⁇ L library was sampled and quantified by qPCR, and was qualified if the concentration of the library is greater than or equal to 20pM. The samples with different linkers in one channel were mixed equally according to the arrangement of the channels. 1 ⁇ L mixture was sampled and quantified again by qPCR.
  • Step 5 Sequencing: the first end sequencing primer, tag primer and the second end sequencing primer were diluted into 100 ⁇ M and sequenced according to the operation instruction of Illmina Hiseq2000. Alternatively, double-ended sequencing or single-ended sequencing can be carried out. The second end sequencing primer is not required when the single-ended sequencing is carried out.
  • the invention also provides a kit for quickly constructing a plasma DNA sequencing library according to Examples 1-4.
  • the kit can include enzymes for filling and repairing the ends of plasma DNA; enzymes for adding an adenine on the 3’ end of the DNA, including T4 DNA polymerase, Klenow enzyme, DNA polymerase, Taq enzyme and klenow ex-enzyme (lacking 3’ -5’ exonuclease activity) ; enzymes for connecting linkers, including T4 DNA ligase, T7 DNA ligase and a combination thereof; and buffers required by the various enzymes; as well as dATP for end-filling and the addition of A on the end, double-stranded sequencing linkers for connecting a linker, and the like.
  • an important feature of the kit of the present invention is that it does not comprise a polymerase for PCR amplification.
  • the invention achieves that the end-filling and the addition of A on the end are carried out in one reaction system, or that the end-filling and the addition of A on the end as well as the connection with sequencing linkers are carried out in one reaction system.
  • the kit of the present invention may not include reagents and devices for purifying the end-filled products and/or may not include reagents and devices for purifying the end-added A products, thereby reducing the cost and simplifying the process for constructing a library.
  • the kit of the present invention may further comprise reagents and devices for purifying the end-filled products; reagents and devices for purifying the end-added A products; and reagents and devices for purifying the products connected with a sequencing linker.
  • the reagents for purification may include sterile dH 2 O or an elution buffer; devices for purification may include a purification column, a Qiagen column, purification magnetic beads or Beckman Ampure XP beads.
  • the reagents and devices for purification are not limited to those specifically listed here. Various reagents and devices commonly used in the art can be used in the present invention according to the judgement of those skilled in the art.

Abstract

La présente invention concerne un procédé de construction d'une banque de séquençage d'ADN plasmatique, comprenant les étapes consistant à extraire de l'ADN plasmatique, à procéder, éventuellement, au remplissage des extrémités de l'ADN plasmatique, à ajouter A sur l'extrémité 3' de l'ADN plasmatique, à relier l'ADN plasmatique à un lieur de séquençage et à purifier le produit ainsi obtenu. Les trois étapes de remplissage des extrémités, d'addition de A et de liaison de l'ADN plasmatique à un lieur peuvent être mises en œuvre au sein d'un unique système réactionnel. L'utilisation de la PCR n'est pas nécessaire pour construire ladite banque. La présente invention concerne également un nécessaire de construction d'une banque de séquençage d'ADN plasmatique.
PCT/CN2014/093698 2014-06-24 2014-12-12 Procédé et nécessaire de construction rapide d'une banque de séquençage d'adn plasmatique WO2015196752A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201410311003.7 2014-06-24
CN201410311003.7A CN105296602B (zh) 2014-06-24 2014-06-24 一种快速构建血浆dna测序文库的方法和试剂盒

Publications (1)

Publication Number Publication Date
WO2015196752A1 true WO2015196752A1 (fr) 2015-12-30

Family

ID=54936659

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2014/093698 WO2015196752A1 (fr) 2014-06-24 2014-12-12 Procédé et nécessaire de construction rapide d'une banque de séquençage d'adn plasmatique

Country Status (3)

Country Link
CN (2) CN105296602B (fr)
HK (1) HK1220994A1 (fr)
WO (1) WO2015196752A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018233236A1 (fr) * 2017-06-21 2018-12-27 Berry Genomics Co., Ltd Procédés et kits de construction d'une bibliothèque de séquençage destinée à être utilisée dans la détection d'une variation de nombre de copies de chromosomes
CN115691665A (zh) * 2022-12-30 2023-02-03 北京求臻医学检验实验室有限公司 基于转录因子的癌症早期筛查诊断方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106148513A (zh) * 2016-06-22 2016-11-23 杭州杰毅麦特医疗器械有限公司 一种游离dna文库构建方法及试剂盒
CN109609597A (zh) * 2018-12-29 2019-04-12 北京优迅医学检验实验室有限公司 一种低起始量PCR-free高通量测序文库的构建方法
CN110129414A (zh) * 2019-04-28 2019-08-16 安徽鼎晶生物科技有限公司 一种brca高通量测序文库及其构建方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013104106A1 (fr) * 2012-01-10 2013-07-18 北京贝瑞和康生物技术有限公司 Procédé de construction d'une banque de séquençage de l'adn plasmatique et nécessaire à cet effet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101921841B (zh) * 2010-06-30 2014-03-12 深圳华大基因科技有限公司 基于Illumina GA测序技术的HLA基因高分辨率分型方法
CN101921840B (zh) * 2010-06-30 2014-06-25 深圳华大基因科技有限公司 一种基于dna分子标签技术和dna不完全打断策略的pcr测序方法
US20120244525A1 (en) * 2010-07-19 2012-09-27 New England Biolabs, Inc. Oligonucleotide Adapters: Compositions and Methods of Use
CN101967476B (zh) * 2010-09-21 2012-11-14 深圳华大基因科技有限公司 一种基于接头连接的DNA PCR-Free标签文库构建方法

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013104106A1 (fr) * 2012-01-10 2013-07-18 北京贝瑞和康生物技术有限公司 Procédé de construction d'une banque de séquençage de l'adn plasmatique et nécessaire à cet effet

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Swift Biosciences Launches Accel-NGS? 2S DNA Library Kit - Dramatically Reduces SampleRequirements For NGS Sample Prep", BIOSPACE - PRINT NEWS ARTICLE, 3 March 2014 (2014-03-03), XP055246700 *
WARTON, K. ET AL.: "Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma", BMC GENOMICS, vol. 15, 15 June 2014 (2014-06-15), pages 476, XP021189032 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018233236A1 (fr) * 2017-06-21 2018-12-27 Berry Genomics Co., Ltd Procédés et kits de construction d'une bibliothèque de séquençage destinée à être utilisée dans la détection d'une variation de nombre de copies de chromosomes
JP2020529219A (ja) * 2017-06-21 2020-10-08 ベリー ゲノミクス カンパニー，リミテッド 染色体コピー数多型の検出に使用するためのシーケンシングライブラリーを構築する方法およびキット
CN115691665A (zh) * 2022-12-30 2023-02-03 北京求臻医学检验实验室有限公司 基于转录因子的癌症早期筛查诊断方法

Also Published As

Publication number Publication date
CN105296602A (zh) 2016-02-03
CN105296602B (zh) 2020-07-17
HK1220994A1 (zh) 2017-05-19
CN111748606A (zh) 2020-10-09

Similar Documents

Publication Publication Date Title
US20220228197A1 (en) Method for determining copy number variations
US20210082538A1 (en) Normalizing chromosomes for the determination and verification of common and rare chromosomal aneuploidies
US20220106639A1 (en) Method for determining copy number variations
US20230340590A1 (en) Method for verifying bioassay samples
CA2840418C (fr) Procede de determination de la presence ou de l'absence d'aneuploides differents dans un echantillon
US20140228256A1 (en) Method and kit for constructing plasma dna sequencing library
WO2015196752A1 (fr) Procédé et nécessaire de construction rapide d'une banque de séquençage d'adn plasmatique
WO2012141712A1 (fr) Normalisation des chromosomes pour la détermination et la vérification d'hétéroploïdies chromosomiques communes et rares
AU2018201992A1 (en) Sequencing methods and compositions for prenatal diagnoses
EP3935164A2 (fr) Procédés d'extraction rapide d'adn à partir d'un tissu et préparation de bibliothèque pour séquençage basé sur des nanopores
AU2015204302B2 (en) Method for determining copy number variations
CN114790455A (zh) 用于扩增gjb2基因和slc26a4基因的引物组、试剂盒和方法

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14896225

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14896225

Country of ref document: EP

Kind code of ref document: A1